ATE299703T1 - Mmp-hemmer bei bindegewebserweichung - Google Patents
Mmp-hemmer bei bindegewebserweichungInfo
- Publication number
- ATE299703T1 ATE299703T1 AT00903808T AT00903808T ATE299703T1 AT E299703 T1 ATE299703 T1 AT E299703T1 AT 00903808 T AT00903808 T AT 00903808T AT 00903808 T AT00903808 T AT 00903808T AT E299703 T1 ATE299703 T1 AT E299703T1
- Authority
- AT
- Austria
- Prior art keywords
- connective tissue
- mmp inhibitors
- tissue softening
- softening
- connective
- Prior art date
Links
- 210000002808 connective tissue Anatomy 0.000 title abstract 4
- 229940124761 MMP inhibitor Drugs 0.000 title 1
- 210000000845 cartilage Anatomy 0.000 abstract 1
- 210000003041 ligament Anatomy 0.000 abstract 1
- 238000012423 maintenance Methods 0.000 abstract 1
- 239000003771 matrix metalloproteinase inhibitor Substances 0.000 abstract 1
- 229940121386 matrix metalloproteinase inhibitor Drugs 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 210000002435 tendon Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- Peptides Or Proteins (AREA)
- Prostheses (AREA)
- Package Frames And Binding Bands (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9903598.2A GB9903598D0 (en) | 1999-02-18 | 1999-02-18 | Connective tissue healing |
| PCT/GB2000/000474 WO2000048617A2 (en) | 1999-02-18 | 2000-02-14 | Connective tissue softening |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE299703T1 true ATE299703T1 (de) | 2005-08-15 |
Family
ID=10847938
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00903808T ATE299703T1 (de) | 1999-02-18 | 2000-02-14 | Mmp-hemmer bei bindegewebserweichung |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6455569B1 (de) |
| EP (1) | EP1152757B1 (de) |
| JP (1) | JP2002537268A (de) |
| AT (1) | ATE299703T1 (de) |
| AU (1) | AU772470B2 (de) |
| CA (1) | CA2362279C (de) |
| DE (1) | DE60021350T2 (de) |
| DK (1) | DK1152757T3 (de) |
| ES (1) | ES2244410T3 (de) |
| GB (1) | GB9903598D0 (de) |
| PT (1) | PT1152757E (de) |
| WO (1) | WO2000048617A2 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6436629B1 (en) * | 2000-10-27 | 2002-08-20 | The Regents Of The University Of California | Modulating angiogenesis |
| WO2004060346A2 (en) | 2002-12-30 | 2004-07-22 | Angiotech International Ag | Drug delivery from rapid gelling polymer composition |
| US20070259030A1 (en) * | 2006-05-05 | 2007-11-08 | Drapeau Susan J | Methods, systems and reagents for tendon and ligament therapy |
| RU2542471C2 (ru) | 2006-11-15 | 2015-02-20 | Коуда Терапьютикс, Инк. | Улучшенные способы и композиции для заживления ран |
| US8323642B2 (en) * | 2006-12-13 | 2012-12-04 | Depuy Mitek, Inc. | Tissue fusion method using collagenase for repair of soft tissue |
| EP2234656A2 (de) | 2007-12-21 | 2010-10-06 | Coda Therapeutics, Inc. | Verbesserte medizinische vorrichtungen |
| AU2008343840A1 (en) * | 2007-12-21 | 2009-07-09 | Coda Therapeutics, Inc. | Use of anti-connexin polynucleotides, peptides or antibodies for the treatment of orthopedic conditions |
| EP2252690A2 (de) * | 2007-12-21 | 2010-11-24 | Coda Therapeutics, Inc. | Verwendung von anti-connexin-43-polynukleotiden zur behandlung abnormaler oder übermässiger narben |
| WO2016029191A2 (en) | 2014-08-22 | 2016-02-25 | Auckland Uniservices Limited | Channel modulators |
| WO2022128057A1 (en) | 2020-12-14 | 2022-06-23 | Symrise Ag | Medicament for prevention and treatment of collagen degradation in human connecting tissue |
| US12667586B2 (en) | 2023-03-07 | 2026-06-30 | Glaukos Corporation | Treatments for ocular surface disorders |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8827305D0 (en) * | 1988-11-23 | 1988-12-29 | British Bio Technology | Compounds |
| US5239078A (en) * | 1990-11-21 | 1993-08-24 | Glycomed Incorporated | Matrix metalloprotease inhibitors |
| US5318964A (en) * | 1992-06-11 | 1994-06-07 | Hoffmann-La Roche Inc. | Hydroxamic derivatives and pharmaceutical compositions |
| US5310759A (en) | 1992-08-12 | 1994-05-10 | Bockman Richard S | Methods of protecting and preserving connective and support tissues |
| CA2160139A1 (en) * | 1993-04-07 | 1994-10-13 | Richard Edward Galardy | Synthetic matrix metalloprotease inhibitors and uses thereof |
| GB9405076D0 (en) | 1994-03-16 | 1994-04-27 | Inst Of Ophtalmology | A medical use of matrix metalloproteinase inhibitors |
| DE19542189A1 (de) | 1995-11-13 | 1997-05-15 | Hoechst Ag | Cyclische N-substituierte alpha-Iminohydroxamsäuren |
| TR199800849T2 (xx) * | 1995-11-13 | 1998-07-21 | Hoechst Aktiengesellschaft | Siklikle heterosiklik N-ikame edilmi� alfa-iminohidroksamla karbon asitleri |
| GB9714936D0 (en) * | 1997-07-17 | 1997-09-17 | Smith & Nephew | Cell culture products |
-
1999
- 1999-02-18 GB GBGB9903598.2A patent/GB9903598D0/en not_active Ceased
-
2000
- 2000-02-14 US US09/913,713 patent/US6455569B1/en not_active Expired - Fee Related
- 2000-02-14 AT AT00903808T patent/ATE299703T1/de active
- 2000-02-14 EP EP00903808A patent/EP1152757B1/de not_active Expired - Lifetime
- 2000-02-14 DK DK00903808T patent/DK1152757T3/da active
- 2000-02-14 DE DE60021350T patent/DE60021350T2/de not_active Expired - Lifetime
- 2000-02-14 CA CA2362279A patent/CA2362279C/en not_active Expired - Fee Related
- 2000-02-14 ES ES00903808T patent/ES2244410T3/es not_active Expired - Lifetime
- 2000-02-14 AU AU25571/00A patent/AU772470B2/en not_active Ceased
- 2000-02-14 JP JP2000599407A patent/JP2002537268A/ja active Pending
- 2000-02-14 WO PCT/GB2000/000474 patent/WO2000048617A2/en not_active Ceased
- 2000-02-14 PT PT00903808T patent/PT1152757E/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000048617A3 (en) | 2001-02-08 |
| ES2244410T3 (es) | 2005-12-16 |
| PT1152757E (pt) | 2005-09-30 |
| CA2362279C (en) | 2010-05-25 |
| CA2362279A1 (en) | 2000-08-24 |
| DE60021350D1 (de) | 2005-08-25 |
| AU2557100A (en) | 2000-09-04 |
| US6455569B1 (en) | 2002-09-24 |
| JP2002537268A (ja) | 2002-11-05 |
| HK1037960A1 (en) | 2002-03-01 |
| DK1152757T3 (da) | 2005-10-31 |
| DE60021350T2 (de) | 2006-04-27 |
| AU772470B2 (en) | 2004-04-29 |
| WO2000048617A2 (en) | 2000-08-24 |
| EP1152757A2 (de) | 2001-11-14 |
| EP1152757B1 (de) | 2005-07-20 |
| GB9903598D0 (en) | 1999-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY135732A (en) | 5,6-trimethylenepyrimidin - 4 - one compounds | |
| DE60137430D1 (de) | Gewebeimplant zur wiederherstellung von knorpelgewebe | |
| ATE225351T1 (de) | Thienopyridin und thienopyrimidinderivate und ihre verwendung als entzündungshemmende mittel | |
| BR0014078A (pt) | Inibidores de fator xa | |
| BR9913255A (pt) | Composto, composição farmacêutica, processo de tratamento de uma condição de doença mediada por metaloproteinase, processo para preparar um composto, e, uso de um composto | |
| TR200103216T2 (tr) | Pirimidinon bileşimleri | |
| DE60023043D1 (de) | (S,S)-Reboxetin zur Behandlung von Inkontinenz | |
| DK0987998T3 (da) | Decellulering af væv | |
| ATE234812T1 (de) | Integrin antagonisten | |
| BR0211274A (pt) | Combinação de um antagonista de receptor de aldosterona e um inibidor de hmg co-a redutase | |
| DE60013859D1 (de) | Indolderivate und deren verwendung zur behandlung von u.a. osteoporosis | |
| WO2004024009A8 (en) | Bone plates | |
| DK1152757T3 (da) | MMP-inhibitorer i bindevævsblödhed | |
| DE60014928D1 (de) | Retinoide zur behandlung von emphysem | |
| MXPA04004372A (es) | Derivados heterociclicos de glicinamida y su uso medico. | |
| DK1079843T3 (da) | Anvendelse af a1beta1 integrinreceptorinhibitorer og TFG beta1 inhibitorer til behandling af nyresygdom | |
| DK1104259T3 (da) | Knoglefikseringsapparat | |
| ES2180514T3 (es) | Uso de un factor con actividad inhibidora del melanoma (mia) para reparacion de cartilagos y huesos. | |
| TR200200278T2 (tr) | Kalsilitik bileşimler | |
| BR0115882A (pt) | Emprego de compostos de 1-fenil-3-dimetilaminopropano no tratamento da incontinência urinária | |
| DE60140864D1 (de) | Therapeutische zusammenfassungen und verfahren zur modulierung von v3, eine isoform von versican | |
| ATE284711T1 (de) | Heilmittel und/oder prophylactische mittel zur behandlung von nervensystem-störungen | |
| MXPA02004699A (es) | Derivados de acidos hidroxieicosatetraenoico modificados con cadena omega y metodos de su uso para el tratameinto del ojo reseco. | |
| BR0112460A (pt) | Método para tratamento de sépsis | |
| DE60007864D1 (de) | Verwendung von antileukoprotease zur behandlung von endometriose |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1152757 Country of ref document: EP |